Keywords: Pfizer, Watson, Actavis, Rapamune, Patent dispute, Organ transplantation

Pfizer prevails in Rapamune patent dispute with Watson

Article | 01 February 2013

Print This

Global pharma behemoth Pfizer (NYSE: PFE) says that the US District Court for the District of Delaware ruled that its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in